A group of autosomal recessive disorders involving a deficiency in an enzyme crucial for cortisol and/or aldosterone synthesis
Congenital adrenal hyperplasia (CAH)
A group of autosomal recessive disorders involving a deficiency in an enzyme crucial for cortisol and/or aldosterone synthesis
Clinical manifestations of CAH
Degree of cortisol deficiency
Degree of aldosterone deficiency
Accumulation of precursor adrenocortical hormones
Clinical manifestations of CAH
Degree of cortisol deficiency
Degree of aldosterone deficiency
Accumulation of precursor adrenocortical hormones
Supraphysiologic precursor concentrations
Lead to excess androgen production causing virilization
Lead to mineralocorticoid properties causing sodium retention and hypertension
Supraphysiologic precursor concentrations
Lead to excess androgen production causing virilization
Lead to mineralocorticoid properties causing sodium retention and hypertension
Phenotype
Determined by the degree or type of gene deletion or mutation
Phenotype
Determined by the degree or type of gene deletion or mutation
Resultant deficiency of the steroidogenic enzyme
Influences the phenotype
Resultant deficiency of the steroidogenic enzyme
Influences the phenotype
Enzymes and corresponding genes
CYP21A codes for 21-hydroxylase enzyme
CYP11B1 codes for 11-beta-hydroxylase enzyme
CYP17A1 codes for 17-alpha-hydroxylase/17,20-lyase enzyme
Enzymes and corresponding genes
CYP21A codes for 21-hydroxylase enzyme
CYP11B1 codes for 11-beta-hydroxylase enzyme
CYP17A1 codes for 17-alpha-hydroxylase/17,20-lyase enzyme
Many enzymes involved in cortisol and aldosterone synthesis are cytochrome P450 (CYP) proteins
Many enzymes involved in cortisol and aldosterone synthesis are cytochrome P450 (CYP) proteins
Two copies of an abnormal gene are needed for disease manifestation
Two copies of an abnormal gene are needed for disease manifestation
Phenotype spectrum
Clinically inapparent disease (occult or cryptic adrenal hyperplasia)
Mild disease expressed in adolescence or adulthood (nonclassic adrenal hyperplasia)
Severe disease that results in adrenal insufficiency in infancy with or without virilization and salt wasting (classic adrenal hyperplasia)
Phenotype spectrum
Clinically inapparent disease (occult or cryptic adrenal hyperplasia)
Mild disease expressed in adolescence or adulthood (nonclassic adrenal hyperplasia)
Severe disease that results in adrenal insufficiency in infancy with or without virilization and salt wasting (classic adrenal hyperplasia)
Most common form (due to 21-hydroxylase deficiency)
Salt-wasting phenotype
Simple virilizing phenotype
Nonclassic phenotype
Most common form (due to 21-hydroxylase deficiency)
Salt-wasting phenotype
Simple virilizing phenotype
Nonclassic phenotype
Patient education
Educate caretakers and patients about the disease nature for understanding adrenal cortical hormone replacement importance
Emphasize the need for extra glucocorticoids during illness/stress to prevent adrenal crises
Teach patients the significance of intramuscular (IM) glucocorticoid injections and proper administration techniques
Patient education
Educate caretakers and patients about the disease nature for understanding adrenal cortical hormone replacement importance
Emphasize the need for extra glucocorticoids during illness/stress to prevent adrenal crises
Teach patients the significance of intramuscular (IM) glucocorticoid injections and proper administration techniques
Clinical phenotype of CAH
Varies with enzyme deficiency nature and severity
Clinical phenotype of CAH
Varies with enzyme deficiency nature and severity
Most common form is 21-hydroxylase deficiency (CYP21)
Most common form is 21-hydroxylase deficiency (CYP21)
About 50% of classic CAH cases from CYP21A mutations have salt wasting due to low aldosterone
About 50% of classic CAH cases from CYP21A mutations have salt wasting due to low aldosterone
Initial neonatal sex determination can be unclear due to genital ambiguity in CAH cases
Initial neonatal sex determination can be unclear due to genital ambiguity in CAH cases
Clinical presentation in females
Classic Virilizing Adrenal Hyperplasia
Simple Virilizing Adrenal Hyperplasia
Nonclassic Adrenal Hyperplasia
17-hydroxylase Deficiency
Clinical presentation in females
Classic Virilizing Adrenal Hyperplasia
Simple Virilizing Adrenal Hyperplasia
Nonclassic Adrenal Hyperplasia
17-hydroxylase Deficiency
Clinical presentation in males
Classic Salt-Wasting Adrenal Hyperplasia
Simple Virilizing Adrenal Hyperplasia in Males
Clinical presentation in males
Classic Salt-Wasting Adrenal Hyperplasia
Simple Virilizing Adrenal Hyperplasia in Males
21-hydroxylase deficiency in males may be mistaken for gastroenteritis or pyloric stenosis, delaying crucial glucocorticoid treatment
21-hydroxylase deficiency in males may be mistaken for gastroenteritis or pyloric stenosis, delaying crucial glucocorticoid treatment
Steroidogenic acute regulatory (StAR) deficiency, classic 3-beta-hydroxysteroid dehydrogenase deficiency, or 17-hydroxylase deficiency can lead to ambiguous or female genitalia in males due to insufficient testosterone in early fetal stages
Steroidogenic acute regulatory (StAR) deficiency, classic 3-beta-hydroxysteroid dehydrogenase deficiency, or 17-hydroxylase deficiency can lead to ambiguous or female genitalia in males due to insufficient testosterone in early fetal stages
Other findings
Signs of Adrenal Insufficiency
Epinephrine Synthesis Impact
Simple Virilizing Adrenal Hyperplasia
Forms of Adrenal Hyperplasia and Hypertension
Diagnostic Factors in CAH due to CYP17A1 Defects
Adrenal Hyperplasia and Genital Development
Aldosterone Deficiency Presentation
11-hydroxylase Deficiency Presentation
StAR Deficiency (Lipoid Adrenal Hyperplasia) Presentation
Other findings
Signs of Adrenal Insufficiency
Epinephrine Synthesis Impact
Simple Virilizing Adrenal Hyperplasia
Forms of Adrenal Hyperplasia and Hypertension
Diagnostic Factors in CAH due to CYP17A1 Defects
Adrenal Hyperplasia and Genital Development
Aldosterone Deficiency Presentation
11-hydroxylase Deficiency Presentation
StAR Deficiency (Lipoid Adrenal Hyperplasia) Presentation